China is experiencing a boom in cosmetic surgery placing it among the fastest-growing medical cosmetic and aesthetic markets in the world, according to a new report by Nasdaq listed So-Young.
Indian and Japanese lab companies Strand Lifesciences and LSI Medience have joined Quest Diagnostic's 'Global Diagnostics Network' ten months after it launched.
Regulation is key in assessing the viability of for-profit fertility markets, according to a recent report from HBI intelligence written after months of discussion with operators in EMEA. More liberal markets are almost always more attractive markets.
For the first time in years, a US-based patient-facing digital healthcare company will IPO. Will this encourage similar companies in Europe to go public? HBI assesses.
There are strong rumours that UK dialysis provider Renal Services will be put up for sale in the next 12 months. CEO and majority shareholder Stefano Ciampolini tells HBI that while there is no process or mandate at the moment, the group is mulling its options.
Private equity group Triton is to acquire Aleris' healthcare services business, nine months after owner Investor AB sold off its social care segment. It values Aleris at 2.6-2.8bn SEK (€246-265m) or 17-18x 2018 EBITDA.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
